androstane-3,17-diol has been researched along with Sterility, Male in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allan, CM; Desai, R; Handelsman, DJ; Hazra, R; Jimenez, M; Noori, O; Upton, D | 1 |
| Adeline, J; Nahoul, K; Roger, M | 1 |
1 review(s) available for androstane-3,17-diol and Sterility, Male
| Article | Year |
|---|---|
[Age-related changes in plasma androstanediol glucuronide in men].
Topics: Adult; Age Factors; Aged; Androstane-3,17-diol; Glucuronates; Humans; Infertility, Male; Male; Middle Aged; Penile Diseases; Radioimmunoassay | 1990 |
1 other study(ies) available for androstane-3,17-diol and Sterility, Male
| Article | Year |
|---|---|
Elevated expression of the Sertoli cell androgen receptor disrupts male fertility.
Topics: Androstane-3,17-diol; Animals; Benzamides; Dihydrotestosterone; Epididymis; Fertility; Homeodomain Proteins; Infertility, Male; Male; Meiosis; Mice, Transgenic; Piperidines; Proteinase Inhibitory Proteins, Secretory; Proteins; Real-Time Polymerase Chain Reaction; Receptors, Androgen; Rete Testis; Sertoli Cells; Spermatogenesis; Spermatozoa; Testis; Transcription Factors | 2016 |